McKesson is buying Precision Medicine Group in a $2.25 billion clinical research bet
The drug distributor will fold the clinical research and biopharma commercialization firm into its oncology unit once the deal closes
We haven't written up this one. Quartz has the full story — the link below goes straight to it.